DXCM INVESTOR ALERT: DexCom, Inc. Investors With Significant Losses Have Option to File Class Action Lawsuit

San Diego, California–(Newsfile Corp. – September 15, 2024) – The law firm of Robbins Geller Rudman & Dowd LLP Announces Purchasers or acquirers of DexCom, Inc. (NASDAQ: DXCM) securities between January 8, 2024 and July 25, 2024, inclusive (the “Class Period”), have until October 21, 2024 to request appointment as lead plaintiff in the Class Period. DexCom class action lawsuit. Subtitled Alonzo v. DexCom, Inc.No. 24-cv-01485 (SD Cal.), the DexCom A class action lawsuit accuses DexCom and certain top DexCom executives of violating the Securities Exchange Act of 1934.

If you have suffered significant losses and wish to serve as lead plaintiff in the case, DexCom For a class action lawsuit, please provide your details here: